| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.20B | -1.4% |
| Cost of Revenue | $1.78B | +1.3% |
| Gross Profit | $1.42B | -4.5% |
| R&D Expense | $329.0M | +4.1% |
| SG&A Expense | $450.6M | +0.9% |
| Operating Income | $455.9M | -14.6% |
| Pre-tax Income | $254.6M | -20.9% |
| Income Tax | $18.0M | -36.5% |
| Net Income | $235.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $360.4M | +9.5% |
| Inventory | $643.2M | +0.8% |
| Current Assets | $1.64B | +1.4% |
| Total Assets | $8.35B | -0.5% |
| Current Liabilities | $488.6M | -7.0% |
| Long-term Debt | $3.70B | -7.1% |
| Stockholders' Equity | $3.95B | +7.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $695.4M | +10.1% |
| Capital Expenditures | $299.2M | -5.2% |
| Investing Cash Flow | -$300.8M | -348.4% |
| Financing Cash Flow | -$366.9M | +46.7% |
| Free Cash Flow | $396.2M | +25.3% |
| -19.5% |
| EPS (Basic) | $1.55 | -20.1% |
| EPS (Diluted) | $1.55 | -19.7% |